This pattern is consistent with the tumor-suppressor effect of TGFβ on primary tumor formation and its subsequent conversion to a promoter of metastatic growth90–92, and the paradoxical effect of EGFR during breast cancer progression93. Here, EGFR is linked to breast carcinoma.